Responsible for shaping and executing the R&D strategy within the oncology therapeutic area as well as leading strategic partnerships in the field. This role drives innovation, identifies high-impact opportunities, and steers cross-functional efforts to
You will be pivotal in ensuring the right drug is delivered at the right dose, safely and efficaciously, to patients. You will lead nonclinical and translational strategies, collaborating across therapeutic areas to transform scientific hypotheses into
Acts as a subject matter expert and escalation lead for complex quality issues, inspection readiness, and quality risk management, and ensures consistent, compliant and inspection-ready execution of quality activities across projects vendors, and systems,
You will drive medical initiatives within project teams, guiding strategic direction and decision-making processes, and offer expert medical and scientific guidance, leveraging therapeutic expertise in obesity studies to inform project development
Evaluate and develop product development strategies for pharmaceutical products (drugs, biologics, advanced therapies) focusing on clinical-commercial convergence that encompasses all phases of development from discovery to market, including preclinical
Develop and lead clinical biomarker strategies across Ipsen's oncology and rare disease portfolio to support critical development and portfolio decisions. Define biomarker plans to support target engagement, pharmacodynamic and mechanistic understanding,